FIELD: biotechnology; medicine.
SUBSTANCE: invention relates to a method of obtaining a suspension of carrageenan-treated neutrophils against murine melanoma B16. The method of obtaining a suspension of carrageenan-treated neutrophils against murine melanoma B16 consists of the following: a mouse is injected with an inflammatory agent intraperitoneally; 7 hours after the administration of the inflammatory agent, 1.5 ml of a buffered saline solution of 400 μg/ml k- or λ-carrageenan gel is injected intraperitoneally to treat neutrophils for 3 hours; 10 ml of buffered saline solution cooled to 4°C is injected intraperitoneally, then the mouse abdomen filled with the solution is subjected to intensive massage for 1 minute; peritoneal fluid is pumped out with a syringe; carrageenan-treated neutrophils are washed using centrifugation at 1,500 rpm for 8 minutes, then the sediment is resuspended in 10 ml of cooled saline and centrifugation is carried out again to wash the cells from the remains of the carrageenan gel.
EFFECT: above method makes it possible to obtain a suspension of neutrophils with specified properties.
1 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SELECTIVE DESTRUCTION OF MACROPHAGES IN CELL SUSPENSION AND WHOLE ORGANISM USING COLLOIDAL SILVER PREPARATIONS - PROTARGOL AND COLLARGOL | 2022 |
|
RU2811772C2 |
METHOD FOR EXPERIMENTAL BIOTHERAPY OF B16/F10 MELANOMA | 2022 |
|
RU2779698C1 |
EXPERIMENTAL METHOD OF TREATING LIVER CANCER BY INTRAPORTAL INTRODUCTION OF ZYMOZAN INCORPORATED INTO PHAGOCYTES | 2011 |
|
RU2485496C2 |
METHOD FOR PREVENTING THE DEVELOPMENT OF MYOCARDIAL INFARCTION IN MICE WITH MELANOMA THAT DEVELOPED AGAINST THE BACKGROUND OF CHRONIC NEUROGENIC PAIN | 2022 |
|
RU2786322C1 |
METHOD OF THE MELANOMA TUMOR NODES FORMATION IN THE BODY OF EXPERIMENTAL ANIMALS | 2022 |
|
RU2796892C1 |
METHOD FOR ENHANCING THE GROWTH OF B16/F10 MELANOMA VERSUS THE GROWTH OF B16/F10 MELANOMA WITH SELF-GRAFTING AND SLOWING THE GROWTH OF LLC (LEWIS CARCINOMA) VERSUS THE GROWTH OF LLC WITH SELF-GRAFTING IN CASE OF MULTIPLE PRIMARY MALIGNANT TUMORS AGAINST THE BACKGROUND OF PRIMARY IMMUNODEFICIENCY | 2021 |
|
RU2759487C1 |
METHOD FOR INCORPORATION OF BIOLOGICALLY ACTIVE MICRO- AND NANOPARTICLES IN NEUTROPHILS | 2016 |
|
RU2633502C2 |
A METHOD FOR MODELING THE PRIMARY MULTIPLE GROWTH OF MALIGNANT TUMORS WITH THE SUPPRESSION OF ONE TUMOR BY ANOTHER IN THE CONDITIONS OF PRIMARY IMMUNODEFICIENCY | 2021 |
|
RU2750127C1 |
METHOD FOR SUPPRESSING THE GROWTH OF B16 MELANOMA IN LABORATORY ANIMALS | 2022 |
|
RU2784443C2 |
METHOD FOR CREATING POLYNEOPLASIA WITH STIMULATION OF TUMOR GROWTH IN CONDITIONS OF PRIMARY IMMUNODEFICIENCY IN EXPERIMENT | 2021 |
|
RU2751930C1 |
Authors
Dates
2024-01-17—Published
2022-08-15—Filed